Are you new to glatiramer acetate?
We understand that starting a new medicine can be challenging, and we want to help you feel confident and comfortable as you start on Glatopa.
Trust that you are getting a quality medicine
- Glatopa contains glatiramer acetate, which has been used to treat relapsing forms of multiple sclerosis for over 20 years1
- Nearly 30,000 people have been prescribed once-daily Glatopa 20 mg/mL, which has been available since 20152
- Brought to you by Sandoz, and one of the leading generic pharmaceutical companies in the world
Choosing a dosing regimen that works for you
You have options as you and your doctor decide on the most appropriate dosing schedule for you. Glatopa is available in 2 dosage strengths:
3-times-a-week 40 mg/mL3
Once-daily 20 mg/mL3
Both the 40 mg/mL and 20 mg/mL dosage strengths are given under the skin (subcutaneous injection). They can be administered with the Glatopaject® injection device, which you will receive free of charge when you enroll in GlatopaCare.
Injection training videos
You can watch our video tutorials at any time to learn more about your device. Common questions are answered in our FAQs, and you can view the Glatopaject Demonstration Video at any time for a refresher on the injection technique.
Glatopaject Instructions for Use
Download this PDF at any time for step-by-step instructions on using Glatopaject.
GlatopaCare—Three steps to start treatment with confidence
Once your doctor prescribes you Glatopa, we can help you start and feel comfortable with your medicine. GlatopaCare support services are also available to family and caregivers.
Enroll in GlatopaCare and the $0 Co-Pay Program
Enrolling in GlatopaCare is a simple way to ensure you get the help you need to start and stay on Glatopa. Just call 1.855.GLATOPA or click the button below to enroll online.
Meet your GlatopaCare Specialist
Your GlatopaCare Specialist can help you with any questions regarding insurance and Co-Pay eligibility.* He or she can also connect you with a Nurse Trainer to assist with injection training.
Dedicated specialists are available 8am-8pm ET M-F. If after hours, leave a message.
Get individualized injection training
Just call 1.855.GLATOPA to set up an appointment.
Your GlatopaCare Nurse Trainer can meet with you at your home or call you on the phone. He or she will provide instruction on administering Glatopa and using the Glatopaject injection device.
Nurse Trainers are also available by phone 24/7. Call a Nurse Trainer with your questions related to Glatopa, at any time of day or night.
Have questions about GlatopaCare?
Call 1.855.GLATOPA (1.855.452.8672) or request a call from a GlatopaCare Specialist
*Glatopa Co-Pay Program Eligibility
The Glatopa Co-Pay Program provides up to $9,000 in annual Co-Pay support for Glatopa prescriptions. This program is not health insurance. This program is for insured patients only; uninsured cash-paying patients are not eligible. Patients are not eligible if prescriptions are paid, in whole or in part, by any state or federally funded programs, including but not limited to Medicare (including Part D, even in the coverage gap) or Medicaid, Medigap, VA, DOD, or TriCare, or private indemnity, or HMO insurance plans that reimburse you for the entire cost of your prescription drugs, or where prohibited by law. Card may not be combined with any other rebate, coupon, or offer. Card has no cash value. Sandoz reserves the right to rescind, revoke, or amend this offer without further notice.
Glatopa® (glatiramer acetate injection) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Important Safety Information
Do not take Glatopa® if you are allergic to glatiramer acetate, mannitol, or any of the ingredients in Glatopa.
Some patients report a short-term reaction right after or within minutes after injecting glatiramer acetate. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain, fast heartbeat, anxiety, and trouble breathing. These symptoms generally appear within seconds to minutes of an injection, last about 15 minutes, and do not require specific treatment. During the postmarketing period, there have been reports of patients with similar symptoms who received emergency medical care. If symptoms become severe, call the emergency phone number in your area. Call your healthcare provider right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe pain at the injection site. If any of the above occurs, do not give yourself any more injections until your healthcare provider tells you to begin again.
Chest pain may occur either as part of the immediate post-injection reaction or on its own. This pain should only last a few minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment. Tell your healthcare provider if you experience chest pain that lasts for a long time or feels very intense.
A permanent indentation under the skin (lipoatrophy) or, rarely, necrosis at the injection site may occur, due to local destruction of fat tissue. Be sure to follow proper injection technique and inform your healthcare provider of any skin changes.
Liver problems, including liver failure, can occur with Glatopa. Call your healthcare provider right away if you have symptoms, such as: nausea, loss of appetite, tiredness, dark colored urine and pale stools, yellowing of your skin or the white part of your eye, bleeding more easily than normal, confusion, sleepiness.
The most common side effects in studies of glatiramer acetate injection are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These are not all of the possible side effects of glatiramer acetate. For a complete list, ask your healthcare provider or pharmacist. Tell your healthcare provider about any side effects you have while taking Glatopa.
To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please see full Prescribing Information for Glatopa.
1. Wynn DR. Enduring Clinical Value of Copaxone (Glatiramer Acetate) in Multiple Sclerosis After 20 Years of Use. Mult Scler Int. 2019:1-19. 2. Data on file [IMS SMART data]. Princeton, NJ: Sandoz Inc; 2020. 3. Glatopa Prescribing Information. Sandoz Inc. April 2022.